(Q34062033)
Statements
Phase II trial of 7 days on/7 days off temozolmide for recurrent high-grade glioma (English)
Seunggu J Han
Annette M Molinaro
Jennifer L Clarke
Michael D Prados
Susan M Chang
Mitchel S Berger
Ashley DeSilva
Nicholas A Butowski
1 reference
1 reference
1 reference